GREENVILLE, S.C., March 26 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) features Willie Gault demonstrating it's latest technology in booth #2875 at the American College of Cardiology Scientific Sessions Monday, March 26, 2007. Willie Gault, Chicago Bears Super Bowl Champion, returns to New Orleans, where in 1986 he played to win the Super Bowl 20 Championship. Gault is demonstrating the Signalife heart-monitoring device, invented by Dr. Budimir Drakulic. Dr. Drakulic's patented breakthrough technology provides a unique platform for biomedical signal acquisition, classification and evaluation for the treatment of cardiovascular diseases.

Willie Gault and other world class Hall of Fame athletes, believe this device will save the lives of athletes and others who die of sudden cardiac arrest in this country and around the world. Gault founded the 501 C 3 charity foundation “Athletes For Life” to provide Signalife (www.signalife.com) heart monitors to YMCA, Boys and Girls Clubs, underprivileged high schools and colleges across the country. Willie Gault will access corporate sponsorship and donations to reach his goal of reducing the prevalence of sudden cardiac death in children and adults who have not already been diagnosed with cardiovascular disease. Gault quotes, “This device is the most important device invented to help prevent sudden heart attacks in people young and old alike. We all have been affected by this problem. On a personal note I have lost six friends over the last two years, so it has become my mission to assist in the fight against cardiovascular disease. I am excited about the possibility of saving lives!” Download PDF

About Heart Tronics, Inc.
Heart Tronics, Inc. engages in the research, development, and marketing of signal-monitoring devices for detecting diseases. It primarily offers patient modules that are used as part of a heart monitor system to acquire, amplify, and process physiological signals associated with a patient’s cardiovascular system. Heart Tronics is based in Greenville, South Carolina. For more information visit http://www.Heart Tronics.com.

Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are “forward-looking” statements. Forward-looking statements involve known and unknown risks, which may cause Heart Tronics’s actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Heart Tronics’s technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Heart Tronics’s technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Heart Tronics’s technology, and the unavailability of financing to complete management’s plans and objectives, including the development of heart monitoring and other biomedical incorporating Heart Tronics’s technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Heart Tronics’s filings with the Securities and Exchange Commission.